
...


By Rachael O'Connor and Lydia Patrick
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
The anti-anxiety medication Xanax has been recalled nationwide.
The drug's distributor, Viatris Specialty LLC, initiated the recall of the 3mg tablets of Xanax XR, sold in 60-tablet bottles, on March 17.
Now, on April 16, the distributor has recalled the pills nationwide.
Read More on Health
The reason for the recall is "failed dissolution specifications," according to a report from the Food and Drug Administration (FDA).
A Viatris company spokesperson told Newsweek: "Patient safety and the quality of our medicines are of the utmost importance to Viatris. The voluntary recall of Xanax XR in the U.S. is specific to one lot of one strength (3mg) of the brand product only, and no other batches of the Xanax XR brand product, or its generics, are impacted.
"The vast majority of patients in the U.S. are dispensed generic alprazolam, which this recall does not affect. Further, the voluntary recall is at the retailer level, as agreed with the FDA, meaning that patients do not need to take any action. Wholesalers and Retailers (pharmacies) have been provided with instruction on how to return the product in question."
It has been classed as a Class II recall, which the FDA describes as "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."
According to the California State Board of Pharmacy, the affected pills were distributed to patients between August 27, 2024, and May 29, 2025, with an expiration date of 02/28/2027, and lot number 8177156.
The Board is encouraging pharmacies "to immediately review their quality assurance and recall policies and procedures to determine if any corrective action is required."
No reports of adverse reactions associated with the lot have so far been announced.
An estimated 3.6 million people receive prescriptions for Xanax in the United States, according to a report from AddictionResource.

...
Xanax, the brand name for alprazolam, is a medication to treat anxiety that slows down the brain and nervous system, known as a CNS depressant.
It's part of a group of medications called benzodiazepines, and works by targeting gamma-aminobutyric acid (GABA) receptors.
GABA is an amino acid and the principal neurotransmitter of the cerebral cortex. It is responsible for managing feelings of excitement and energy but if out of balance, can trigger excessive feelings of anxiety.
Taking Xanax calms the GABA receptors, making users more relaxed and less anxious. It is generally considered to be an effective treatment to manage anxiety when taken as prescribed, but it can be abused and cause addiction.
A class II recall is lower than a Class I recall, which the FDA defines as "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death."
However, it is higher than a Class III recall, which the FDA describes as "a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences."
Update 04/16/2026, 10:00 a.m. E.T: This article has been updated to include comment from a Viatris company spokesperson.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines